(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LCN2 mRNA] CTD PMID:31150632 (-)-citrinin increases expression EXP 6480464 Citrinin results in increased expression of LCN2 mRNA CTD PMID:23856526 1,1-dichloroethene increases expression ISO RGD:69454 6480464 vinylidene chloride results in increased expression of LCN2 mRNA CTD PMID:26682919 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA CTD PMID:18289764 more ... 1-naphthyl isothiocyanate multiple interactions ISO RGD:69454 6480464 pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA], PPARA protein affects the reaction [pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA]] CTD PMID:27853831 1-naphthyl isothiocyanate increases expression ISO RGD:69454 6480464 1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA CTD PMID:27853831 11-deoxycorticosterone multiple interactions EXP 6480464 [Desoxycorticosterone co-treated with Sodium Chloride more ... CTD PMID:21135038 17alpha-ethynylestradiol multiple interactions ISO RGD:69454 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LCN2 mRNA, Ethinyl Estradiol inhibits the reaction [IL1B protein results in increased expression of LCN2 mRNA] CTD PMID:12072388 , PMID:17942748 17alpha-ethynylestradiol increases expression ISO RGD:69454 6480464 Ethinyl Estradiol results in increased expression of LCN2 mRNA CTD PMID:16467188 , PMID:17942748 17beta-estradiol multiple interactions ISO RGD:69453 6480464 [Estradiol co-treated with Medroxyprogesterone Acetate] results in decreased expression of LCN2 mRNA more ... CTD PMID:15866426 more ... 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of LCN2 mRNA CTD PMID:15456929 , PMID:26945725 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LCN2 mRNA, [Estradiol co-treated with Plant Preparations] results in increased expression of LCN2 mRNA CTD PMID:26945725 , PMID:32741896 17beta-estradiol increases expression ISO RGD:69454 6480464 Estradiol results in increased expression of LCN2 mRNA CTD PMID:15289156 more ... 17beta-estradiol increases expression ISO RGD:69453 6480464 Estradiol results in increased expression of LCN2 mRNA CTD PMID:19619570 17beta-estradiol affects expression ISO RGD:69454 6480464 Estradiol affects the expression of LCN2 mRNA CTD PMID:15598610 17beta-estradiol multiple interactions ISO RGD:69454 6480464 Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of LCN2 mRNA], Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of LCN2 mRNA] CTD PMID:16977382 , PMID:24052564 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LCN2 mRNA CTD PMID:32741896 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:27291303 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:69454 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69454 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of LCN2 mRNA more ... CTD PMID:15667827 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:69454 6480464 Tetrachlorodibenzodioxin affects the expression of LCN2 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of LCN2 mRNA CTD PMID:20959002 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69454 6480464 Tetrachlorodibenzodioxin results in increased expression of LCN2 mRNA CTD PMID:17949056 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:69454 6480464 Tetrachlorodibenzodioxin results in decreased expression of LCN2 mRNA CTD PMID:16611356 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69453 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of LCN2 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69453 6480464 Tetrachlorodibenzodioxin results in increased expression of LCN2 mRNA CTD PMID:19619570 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO RGD:69454 6480464 2 more ... CTD PMID:25768209 2,3,7,8-Tetrachlorodibenzofuran multiple interactions ISO RGD:69454 6480464 AHR protein promotes the reaction [2 more ... CTD PMID:25768209 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO RGD:69454 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LCN2 mRNA] CTD PMID:18200517 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:69454 6480464 Trinitrobenzenesulfonic Acid results in increased expression of LCN2 mRNA CTD PMID:17982090 , PMID:18200517 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of LCN2 mRNA CTD PMID:21346803 2-amino-2-deoxy-D-glucopyranose decreases expression ISO RGD:69454 6480464 Glucosamine results in decreased expression of LCN2 mRNA CTD PMID:17178593 2-hydroxypropanoic acid decreases expression ISO RGD:69453 6480464 Lactic Acid results in decreased expression of LCN2 mRNA CTD PMID:30851411 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases secretion EXP 6480464 Puromycin Aminonucleoside results in increased secretion of LCN2 protein CTD PMID:20438795 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:20959002 3,4-dichloroaniline increases expression ISO RGD:69453 6480464 3, 4-dichloroaniline results in increased expression of LCN2 mRNA CTD PMID:24172598 3,4-dichloroaniline increases expression EXP 6480464 3, 4-dichloroaniline results in increased expression of LCN2 mRNA CTD PMID:24172598 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of LCN2 mRNA CTD PMID:20409345 3-chloropropane-1,2-diol multiple interactions ISO RGD:69454 6480464 [alpha-Chlorohydrin co-treated with glycidol] results in increased expression of LCN2 mRNA CTD PMID:33187795 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69454 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LCN2 mRNA CTD PMID:16054899 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of LCN2 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol decreases expression ISO RGD:69454 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of LCN2 mRNA CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:69454 6480464 Fenretinide results in increased expression of LCN2 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide increases expression ISO RGD:69453 6480464 Fenretinide results in increased expression of LCN2 mRNA, Fenretinide results in increased expression of LCN2 protein CTD PMID:16671099 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of LCN2 mRNA CTD PMID:22504374 8-anilinonaphthalene-1-sulfonic acid affects binding ISO RGD:69453 6480464 1-anilino-8-naphthalenesulfonate binds to LCN2 protein CTD PMID:16461020 9-cis-retinoic acid increases expression ISO RGD:69453 6480464 Alitretinoin results in increased expression of LCN2 mRNA CTD PMID:15982314 acetylsalicylic acid multiple interactions EXP 6480464 Aspirin inhibits the reaction [Azoxymethane results in decreased expression of LCN2 mRNA] CTD PMID:20043115 Actein increases expression EXP 6480464 actein results in increased expression of LCN2 protein CTD PMID:29969672 adefovir increases secretion EXP 6480464 adefovir results in increased secretion of LCN2 protein CTD PMID:27742868 adefovir pivoxil increases secretion ISO RGD:69453 6480464 adefovir dipivoxil results in increased secretion of LCN2 protein CTD PMID:24714768 aflatoxin B1 increases expression ISO RGD:69454 6480464 Aflatoxin B1 results in increased expression of LCN2 mRNA CTD PMID:19770486 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of LCN2 mRNA CTD PMID:33354967 aflatoxin B1 increases methylation ISO RGD:69453 6480464 Aflatoxin B1 results in increased methylation of LCN2 intron CTD PMID:30157460 Aflatoxin B2 alpha decreases methylation ISO RGD:69453 6480464 aflatoxin B2 results in decreased methylation of LCN2 intron CTD PMID:30157460 agomelatine multiple interactions EXP 6480464 agomelatine inhibits the reaction [Dietary Fats results in increased expression of LCN2 protein] CTD PMID:34081941 aldehydo-D-glucosamine decreases expression ISO RGD:69454 6480464 Glucosamine results in decreased expression of LCN2 mRNA CTD PMID:17178593 all-trans-4-oxoretinoic acid increases expression ISO RGD:69453 6480464 4-oxoretinoic acid results in increased expression of LCN2 mRNA CTD PMID:15982314 all-trans-retinoic acid increases expression ISO RGD:69453 6480464 Tretinoin metabolite results in increased expression of LCN2 mRNA more ... CTD PMID:15982314 more ... all-trans-retinoic acid increases secretion ISO RGD:69453 6480464 Tretinoin results in increased secretion of LCN2 protein CTD PMID:16671099 aluminium oxide multiple interactions ISO RGD:69454 6480464 [Nanotubes, Carbon co-treated with Aluminum Oxide] results in increased secretion of LCN2 protein CTD PMID:25598225 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of LCN2 mRNA CTD PMID:16483693 amphotericin B decreases expression ISO RGD:69453 6480464 Amphotericin B analog results in decreased expression of LCN2 mRNA CTD PMID:28534445 amphotericin B methyl ester increases expression ISO RGD:69454 6480464 methylamphotericin B results in increased expression of LCN2 mRNA CTD PMID:22863853 anthocyanin multiple interactions EXP 6480464 Anthocyanins inhibits the reaction [Carbon Tetrachloride results in increased expression of LCN2 protein] CTD PMID:30825423 aristolochic acid A multiple interactions EXP 6480464 [aristolochic acid I co-treated with aristolochic acid II] results in increased expression of LCN2 protein CTD PMID:23912714 arsenous acid increases expression ISO RGD:69453 6480464 Arsenic Trioxide results in increased expression of LCN2 mRNA CTD PMID:19763917 atorvastatin calcium multiple interactions ISO RGD:69454 6480464 [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of LCN2 mRNA CTD PMID:29679711 atorvastatin calcium multiple interactions EXP 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of LCN2 protein], Atorvastatin inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of LCN2 protein] CTD PMID:32259528 bacitracin increases expression EXP 6480464 Bacitracin results in increased expression of LCN2 mRNA CTD PMID:18289764 benzo[a]pyrene decreases expression ISO RGD:69454 6480464 Benzo(a)pyrene results in decreased expression of LCN2 mRNA CTD PMID:19770486 benzo[a]pyrene multiple interactions ISO RGD:69454 6480464 [corannulene co-treated with Benzo(a)pyrene] results in decreased expression of LCN2 mRNA CTD PMID:32417428 benzo[a]pyrene decreases methylation ISO RGD:69453 6480464 Benzo(a)pyrene results in decreased methylation of LCN2 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:69453 6480464 Benzo(a)pyrene affects the methylation of LCN2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:69454 6480464 Benzo(a)pyrene results in increased expression of LCN2 mRNA CTD PMID:22228805 , PMID:22610609 benzo[a]pyrene affects expression ISO RGD:69454 6480464 Benzo(a)pyrene affects the expression of LCN2 mRNA CTD PMID:22342234 benzo[a]pyrene increases expression ISO RGD:69453 6480464 Benzo(a)pyrene results in increased expression of LCN2 mRNA CTD PMID:22316170 Benzo[ghi]perylene increases expression ISO RGD:69454 6480464 1, 12-benzoperylene results in increased expression of LCN2 mRNA CTD PMID:26377693 beta-D-glucosamine decreases expression ISO RGD:69454 6480464 Glucosamine results in decreased expression of LCN2 mRNA CTD PMID:17178593 bicalutamide increases expression ISO RGD:69453 6480464 bicalutamide results in increased expression of LCN2 mRNA CTD PMID:15638997 bis(2-ethylhexyl) phthalate increases expression ISO RGD:69454 6480464 Diethylhexyl Phthalate results in increased expression of LCN2 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA CTD PMID:31199487 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:69454 6480464 Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of LCN2 mRNA], PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of LCN2 mRNA] CTD PMID:19850644 , PMID:33484791 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of LCN2 mRNA CTD PMID:15456929 bisphenol A increases expression ISO RGD:69454 6480464 bisphenol A results in increased expression of LCN2 mRNA CTD PMID:32156529 , PMID:34281243 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of LCN2 mRNA CTD PMID:32145629 , PMID:34947998 bisphenol A increases expression ISO RGD:69453 6480464 bisphenol A results in increased expression of LCN2 mRNA CTD PMID:29718440 bisphenol A decreases expression ISO RGD:69454 6480464 bisphenol A results in decreased expression of LCN2 mRNA, bisphenol A results in decreased expression of LCN2 protein CTD PMID:27312807 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of LCN2 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:69454 6480464 [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LCN2 mRNA] CTD PMID:27082013 bisphenol A affects expression ISO RGD:69454 6480464 bisphenol A affects the expression of LCN2 mRNA CTD PMID:27082013 bleomycin A2 increases expression ISO RGD:69454 6480464 Bleomycin results in increased expression of LCN2 mRNA, Bleomycin results in increased expression of LCN2 protein CTD PMID:26345256 Botulinum toxin type A increases expression ISO RGD:69454 6480464 Botulinum Toxins, Type A results in increased expression of LCN2 mRNA CTD PMID:33529366 butanal increases expression ISO RGD:69453 6480464 butyraldehyde results in increased expression of LCN2 mRNA CTD PMID:26079696 Butylbenzyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA CTD PMID:31199487 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of LCN2 mRNA CTD PMID:20471445 cadmium atom multiple interactions ISO RGD:69453 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LCN2 mRNA CTD PMID:29741670 cadmium atom increases expression ISO RGD:69453 6480464 Cadmium results in increased expression of LCN2 protein CTD PMID:33603096 cadmium dichloride increases expression ISO RGD:69453 6480464 Cadmium Chloride results in increased expression of LCN2 mRNA CTD PMID:21457566 cadmium dichloride multiple interactions EXP 6480464 Curcumin inhibits the reaction [Cadmium Chloride results in increased export of LCN2 protein] CTD PMID:29421648 cadmium dichloride increases export EXP 6480464 Cadmium Chloride results in increased export of LCN2 protein CTD PMID:29421648 cadmium dichloride multiple interactions ISO RGD:69453 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of LCN2 mRNA CTD PMID:29741670 cadmium dichloride decreases secretion ISO RGD:69453 6480464 Cadmium Chloride results in decreased secretion of LCN2 protein CTD PMID:27888128 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of LCN2 mRNA CTD PMID:25993096 cadmium dichloride increases expression ISO RGD:69454 6480464 Cadmium Chloride results in increased expression of LCN2 mRNA CTD PMID:24982889 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of LCN2 mRNA CTD PMID:22110744 calcitriol increases expression ISO RGD:69453 6480464 Calcitriol results in increased expression of LCN2 mRNA CTD PMID:26485663 cannabidiol increases expression ISO RGD:69454 6480464 Cannabidiol results in increased expression of LCN2 mRNA CTD PMID:21542829 cannabidiol increases expression ISO RGD:69453 6480464 Cannabidiol results in increased expression of LCN2 mRNA CTD PMID:33244087 carbon nanotube multiple interactions ISO RGD:69454 6480464 [Nanotubes, Carbon co-treated with Aluminum Oxide] results in increased secretion of LCN2 protein CTD PMID:25598225 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon results in increased expression of LCN2 mRNA CTD PMID:19836432 , PMID:24911292 carbon nanotube increases secretion ISO RGD:69454 6480464 Nanotubes, Carbon results in increased secretion of LCN2 protein CTD PMID:25598225 carbon nanotube increases expression ISO RGD:69454 6480464 Nanotubes more ... CTD PMID:25554681 more ... carmustine increases response to substance ISO RGD:69453 6480464 LCN2 protein results in increased susceptibility to Carmustine CTD PMID:19860839 carmustine increases response to substance EXP 6480464 LCN2 protein results in increased susceptibility to Carmustine CTD PMID:19860839 carmustine multiple interactions EXP 6480464 [LCN2 protein co-treated with Carmustine] results in increased cleavage of and results in increased activity of CASP3 protein, LCN2 protein promotes the reaction [Carmustine results in decreased phosphorylation of AKT1 protein] CTD PMID:19860839 carnosic acid decreases expression ISO RGD:69454 6480464 salvin results in decreased expression of LCN2 protein CTD PMID:35926579 cerium trichloride increases expression ISO RGD:69454 6480464 cerous chloride results in increased expression of LCN2 mRNA CTD PMID:23573234 chlordecone increases expression ISO RGD:69454 6480464 Chlordecone results in increased expression of LCN2 mRNA CTD PMID:33711761 chloroquine increases expression EXP 6480464 Chloroquine results in increased expression of LCN2 mRNA CTD PMID:19393257 cholesterol multiple interactions ISO RGD:69454 6480464 [Cholesterol co-treated with 1, 2-dioleoyloxy-3-(trimethylammonium)propane] results in increased expression of LCN2 mRNA CTD PMID:22129739 choline multiple interactions ISO RGD:69454 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of LCN2 mRNA more ... CTD PMID:29246445 , PMID:34416350 ciprofibrate increases expression ISO RGD:69454 6480464 ciprofibrate results in increased expression of LCN2 mRNA CTD PMID:12771043 ciprofloxacin multiple interactions ISO RGD:69454 6480464 [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of LCN2 mRNA CTD PMID:29679711 cisplatin increases secretion EXP 6480464 Cisplatin results in increased secretion of LCN2 protein CTD PMID:28885000 cisplatin multiple interactions EXP 6480464 Cisplatin results in increased expression of and results in increased export of LCN2 protein, vanillin inhibits the reaction [Cisplatin results in increased expression of LCN2 protein] CTD PMID:29216766 , PMID:32110797 cisplatin increases expression ISO RGD:69453 6480464 Cisplatin results in increased expression of LCN2 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:69453 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of LCN2 mRNA CTD PMID:27392435 cisplatin decreases secretion ISO RGD:69453 6480464 Cisplatin results in decreased secretion of LCN2 protein CTD PMID:27888128 cisplatin increases expression ISO RGD:69454 6480464 Cisplatin results in increased expression of LCN2 mRNA CTD PMID:24001450 , PMID:34785303 cisplatin multiple interactions ISO RGD:69454 6480464 ferrostatin-1 inhibits the reaction [Cisplatin results in increased expression of LCN2 mRNA] more ... CTD PMID:24001450 , PMID:34785303 cisplatin increases response to substance EXP 6480464 LCN2 protein results in increased susceptibility to Cisplatin CTD PMID:19860839 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of LCN2 mRNA, Cisplatin results in increased expression of LCN2 protein CTD PMID:15033597 more ... cobalt dichloride decreases expression ISO RGD:69453 6480464 cobaltous chloride results in decreased expression of LCN2 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:69453 6480464 [NSC 689534 binds to Copper] which results in increased expression of LCN2 mRNA CTD PMID:20971185 copper atom increases secretion ISO RGD:69454 6480464 Copper results in increased secretion of LCN2 protein CTD PMID:19635393 copper(0) multiple interactions ISO RGD:69453 6480464 [NSC 689534 binds to Copper] which results in increased expression of LCN2 mRNA CTD PMID:20971185 copper(0) increases secretion ISO RGD:69454 6480464 Copper results in increased secretion of LCN2 protein CTD PMID:19635393 corn oil increases expression EXP 6480464 Corn Oil results in increased expression of LCN2 mRNA CTD PMID:22760963 crocidolite asbestos increases expression ISO RGD:69454 6480464 Asbestos, Crocidolite results in increased expression of LCN2 mRNA CTD PMID:23917077 curcumin multiple interactions ISO RGD:69454 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of LCN2 mRNA] CTD PMID:18200517 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [Cadmium Chloride results in increased export of LCN2 protein], Curcumin inhibits the reaction [maleic acid results in increased secretion of LCN2 protein] CTD PMID:25119790 , PMID:29421648 cyanuric acid multiple interactions EXP 6480464 [cyanuric acid co-treated with melamine] results in increased expression of LCN2 mRNA, [melamine co-treated with cyanuric acid] results in increased expression of LCN2 mRNA CTD PMID:21784140 , PMID:23022069 cyclophosphamide increases expression ISO RGD:69454 6480464 Cyclophosphamide results in increased expression of LCN2 mRNA CTD PMID:15331540 , PMID:18433785 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of LCN2 mRNA CTD PMID:20623750 cyclophosphamide multiple interactions ISO RGD:69454 6480464 [Cyclophosphamide co-treated with Mecamylamine] results in increased expression of LCN2 mRNA CTD PMID:18433785 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of LCN2 mRNA CTD PMID:21865292 cyclosporin A multiple interactions ISO RGD:69454 6480464 ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Cyclosporine results in increased expression of LCN2 mRNA], TLR4 gene mutant form inhibits the reaction [Cyclosporine results in increased expression of LCN2 mRNA] CTD PMID:27585667 cyclosporin A increases expression ISO RGD:69453 6480464 Cyclosporine results in increased expression of LCN2 mRNA CTD PMID:20106945 more ... cyclosporin A increases expression ISO RGD:69454 6480464 Cyclosporine results in increased expression of LCN2 mRNA CTD PMID:23958496 , PMID:27585667 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of LCN2 mRNA CTD PMID:21865292 dapagliflozin multiple interactions EXP 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of LCN2 protein] more ... CTD PMID:30551545 , PMID:32259528 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of LCN2 mRNA CTD PMID:23640034 deferasirox increases expression ISO RGD:69454 6480464 deferasirox results in increased expression of LCN2 protein CTD PMID:21439361 deferasirox increases expression EXP 6480464 deferasirox results in increased expression of LCN2 protein CTD PMID:21439361 desferrioxamine B multiple interactions ISO RGD:69454 6480464 Deferoxamine affects the reaction [Magnetite Nanoparticles results in increased expression of LCN2 mRNA], Deferoxamine inhibits the reaction [LCN2 protein results in decreased secretion of VEGFA protein] CTD PMID:17114340 , PMID:23086747 desferrioxamine B increases expression ISO RGD:69454 6480464 Deferoxamine results in increased expression of LCN2 mRNA CTD PMID:23086747 dexamethasone multiple interactions ISO RGD:69454 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of LCN2 mRNA CTD PMID:16054899 dexamethasone decreases secretion ISO RGD:69454 6480464 Dexamethasone results in decreased secretion of LCN2 protein CTD PMID:28003376 dexamethasone increases expression ISO RGD:69454 6480464 Dexamethasone results in increased expression of LCN2 mRNA CTD PMID:23493372 , PMID:23946490 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [Freund's Adjuvant results in increased expression of LCN2 mRNA] CTD PMID:21149847 dextran sulfate increases expression ISO RGD:69454 6480464 Dextran Sulfate results in increased expression of LCN2 mRNA CTD PMID:23894361 dextran sulfate multiple interactions ISO RGD:69454 6480464 AHR gene mutant form promotes the reaction [Dextran Sulfate results in increased expression of LCN2 mRNA] CTD PMID:36519841 Di-n-octyl phthalate multiple interactions ISO RGD:69453 6480464 [Phthalic Acids results in increased abundance of di-n-octyl phthalate metabolite] which results in increased secretion of LCN2 protein CTD PMID:33052911 diarsenic trioxide increases expression ISO RGD:69453 6480464 Arsenic Trioxide results in increased expression of LCN2 mRNA CTD PMID:19763917 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of LCN2 mRNA CTD PMID:21266533 dibutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA CTD PMID:31199487 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of LCN2 mRNA CTD PMID:23939143 diclofenac increases expression ISO RGD:69454 6480464 Diclofenac results in increased expression of LCN2 mRNA CTD PMID:26934552 diclofenac multiple interactions EXP 6480464 Diclofenac inhibits the reaction [lipopolysaccharide more ... CTD PMID:23939143 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of LCN2 mRNA CTD PMID:22546817 diethyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA CTD PMID:31199487 diethylstilbestrol increases expression ISO RGD:69454 6480464 Diethylstilbestrol results in increased expression of LCN2 mRNA CTD PMID:15289156 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of LCN2 mRNA CTD PMID:21658437 diisobutyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA CTD PMID:31199487 diisononyl phthalate multiple interactions EXP 6480464 [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of LCN2 mRNA CTD PMID:31199487 dioxygen increases expression EXP 6480464 Oxygen results in increased expression of LCN2 mRNA CTD PMID:22911455 dioxygen multiple interactions ISO RGD:69454 6480464 [N-(oxo-5 more ... CTD PMID:19640911 , PMID:30529165 diquat increases expression ISO RGD:69454 6480464 Diquat results in increased expression of LCN2 mRNA CTD PMID:36851058 diuron increases expression EXP 6480464 Diuron metabolite results in increased expression of LCN2 mRNA CTD PMID:24172598 doxorubicin multiple interactions ISO RGD:69454 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of LCN2 mRNA, Folic Acid inhibits the reaction [Doxorubicin results in increased expression of LCN2 mRNA] CTD PMID:21040762 , PMID:28608983 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of LCN2 mRNA CTD PMID:35987278 doxorubicin multiple interactions EXP 6480464 Tannic Acid inhibits the reaction [Doxorubicin results in increased expression of LCN2 mRNA] CTD PMID:35987278 doxorubicin increases secretion EXP 6480464 Doxorubicin results in increased secretion of LCN2 protein CTD PMID:28885000 doxorubicin increases expression ISO RGD:69454 6480464 Doxorubicin results in increased expression of LCN2 mRNA CTD PMID:15033991 more ... doxycycline multiple interactions ISO RGD:69454 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of LCN2 mRNA] CTD PMID:18089841 enilconazole increases expression ISO RGD:69454 6480464 enilconazole results in increased expression of LCN2 CTD PMID:27393971 epoxiconazole increases expression ISO RGD:69454 6480464 epoxiconazole results in increased expression of LCN2 mRNA CTD PMID:35436446 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of LCN2 mRNA CTD PMID:16946407 ethanol multiple interactions ISO RGD:69454 6480464 [Ethanol co-treated with Carbon Tetrachloride] results in increased expression of LCN2 mRNA CTD PMID:28285099 etoposide increases response to substance EXP 6480464 LCN2 protein results in increased susceptibility to Etoposide CTD PMID:19860839 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of LCN2 mRNA CTD PMID:31524104 ferric ammonium citrate multiple interactions ISO RGD:69454 6480464 ferric ammonium citrate inhibits the reaction [bathophenanthroline disulfonic acid results in decreased expression of LCN2 protein] CTD PMID:17350462 ferrostatin-1 multiple interactions ISO RGD:69454 6480464 ferrostatin-1 inhibits the reaction [Cisplatin results in increased expression of LCN2 mRNA] CTD PMID:34785303 fluconazole increases expression EXP 6480464 Fluconazole results in increased expression of LCN2 mRNA CTD PMID:20623750 folic acid increases expression ISO RGD:69454 6480464 Folic Acid results in increased expression of LCN2 protein CTD PMID:23255615 folic acid multiple interactions ISO RGD:69454 6480464 EGFR protein affects the reaction [Folic Acid results in increased expression of LCN2 protein] more ... CTD PMID:23255615 , PMID:28608983 fragrance decreases expression ISO RGD:69453 6480464 Perfume results in decreased expression of LCN2 mRNA CTD PMID:24768652 fructose multiple interactions EXP 6480464 [dapagliflozin co-treated with Atorvastatin] inhibits the reaction [[Fructose co-treated with Dietary Fats] results in increased expression of LCN2 protein] more ... CTD PMID:30551545 , PMID:32259528 furan increases expression ISO RGD:69454 6480464 furan results in increased expression of LCN2 mRNA CTD PMID:24183702 gefitinib multiple interactions ISO RGD:69454 6480464 Gefitinib promotes the reaction [Folic Acid results in increased expression of LCN2 protein] CTD PMID:23255615 gemfibrozil multiple interactions ISO RGD:69454 6480464 [Buthionine Sulfoximine co-treated with Lovastatin co-treated with Gemfibrozil] results in increased expression of LCN2 mRNA CTD PMID:30853469 genistein increases expression ISO RGD:69454 6480464 Genistein results in increased expression of LCN2 mRNA CTD PMID:15289156 gentamycin multiple interactions EXP 6480464 Gentamicins results in increased expression of and results in increased export of LCN2 protein, Gentamicins results in increased expression of and results in increased secretion of LCN2 protein CTD PMID:19349640 , PMID:32110797 gentamycin decreases secretion ISO RGD:69453 6480464 Gentamicins results in decreased secretion of LCN2 protein CTD PMID:27888128 gentamycin increases secretion EXP 6480464 Gentamicins results in increased secretion of LCN2 protein CTD PMID:20816719 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of LCN2 mRNA, Gentamicins results in increased expression of LCN2 protein CTD PMID:17636248 more ... glafenine increases expression EXP 6480464 Glafenine results in increased expression of LCN2 mRNA CTD PMID:24136188 glycidol multiple interactions ISO RGD:69454 6480464 [alpha-Chlorohydrin co-treated with glycidol] results in increased expression of LCN2 mRNA CTD PMID:33187795 glycidyl methacrylate decreases expression ISO RGD:69453 6480464 glycidyl methacrylate results in decreased expression of LCN2 protein CTD PMID:36641056 graphene oxide increases expression ISO RGD:69454 6480464 graphene oxide results in increased expression of LCN2 mRNA CTD PMID:33227293 graphite increases expression EXP 6480464 Graphite results in increased expression of LCN2 mRNA CTD PMID:29933104 Hexachloro-1,3-butadiene decreases expression EXP 6480464 hexachlorobutadiene results in decreased expression of LCN2 mRNA CTD PMID:21905055 Hexachloro-1,3-butadiene increases expression EXP 6480464 hexachlorobutadiene results in increased expression of LCN2 protein CTD PMID:21259293 Hexachloro-1,3-butadiene affects expression EXP 6480464 hexachlorobutadiene affects the expression of LCN2 mRNA CTD PMID:21905055 hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of LCN2 mRNA CTD PMID:15159207 hydroquinone increases expression ISO RGD:69453 6480464 hydroquinone results in increased expression of LCN2 mRNA CTD PMID:31256213 iomeprol multiple interactions EXP 6480464 [Streptozocin co-treated with iomeprol] results in increased expression of LCN2 protein, palmidrol analog inhibits the reaction [[Streptozocin co-treated with iomeprol] results in increased expression of LCN2 protein] CTD PMID:26474837 iron atom affects metabolic processing ISO RGD:69454 6480464 LCN2 protein affects the metabolism of Iron CTD PMID:17194590 iron atom increases expression ISO RGD:69454 6480464 Iron results in increased expression of LCN2 mRNA, Iron results in increased expression of LCN2 protein CTD PMID:17350462 iron(0) increases expression ISO RGD:69454 6480464 Iron results in increased expression of LCN2 mRNA, Iron results in increased expression of LCN2 protein CTD PMID:17350462 iron(0) affects metabolic processing ISO RGD:69454 6480464 LCN2 protein affects the metabolism of Iron CTD PMID:17194590 isocyanuric acid multiple interactions EXP 6480464 [cyanuric acid co-treated with melamine] results in increased expression of LCN2 mRNA, [melamine co-treated with cyanuric acid] results in increased expression of LCN2 mRNA CTD PMID:21784140 , PMID:23022069 isoniazide increases expression EXP 6480464 Isoniazid results in increased expression of LCN2 mRNA CTD PMID:20623750 isoprenaline multiple interactions ISO RGD:69454 6480464 Doxycycline inhibits the reaction [Isoproterenol results in increased expression of LCN2 mRNA] CTD PMID:18089841 isoprenaline increases expression ISO RGD:69454 6480464 Isoproterenol results in increased expression of LCN2 mRNA CTD PMID:18089841 , PMID:20003209 isotretinoin increases expression ISO RGD:69453 6480464 Isotretinoin results in increased expression of LCN2 mRNA CTD PMID:15982314 , PMID:18769122 ketamine multiple interactions ISO RGD:69454 6480464 [Ketamine co-treated with Xylazine] results in decreased secretion of LCN2 protein CTD PMID:30538007 ketoconazole decreases expression EXP 6480464 Ketoconazole results in decreased expression of LCN2 mRNA CTD PMID:18289764 L-methionine multiple interactions ISO RGD:69454 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Dietary Fats] promotes the reaction [cyanoginosin LR results in increased expression of LCN2 protein] more ... CTD PMID:34416350 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of LCN2 mRNA CTD PMID:22641619 lead diacetate multiple interactions ISO RGD:69454 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased expression of LCN2 mRNA] CTD PMID:36539177 lead diacetate increases expression ISO RGD:69454 6480464 lead acetate results in increased expression of LCN2 mRNA CTD PMID:36539177 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of LCN2 mRNA CTD PMID:36539177 lead(0) increases expression ISO RGD:69454 6480464 Lead results in increased expression of LCN2 mRNA CTD PMID:34742682 lead(0) multiple interactions ISO RGD:69454 6480464 Dietary Fats promotes the reaction [Lead results in increased expression of LCN2 mRNA], Lead promotes the reaction [Dietary Fats results in increased expression of LCN2 mRNA] CTD PMID:34742682 lipopolysaccharide multiple interactions ISO RGD:69454 6480464 Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of LCN2 mRNA] more ... CTD PMID:16977382 , PMID:18292240 lipopolysaccharide increases expression ISO RGD:69454 6480464 Lipopolysaccharides results in increased expression of LCN2 mRNA, Lipopolysaccharides results in increased expression of LCN2 protein CTD PMID:16977382 more ... lovastatin multiple interactions ISO RGD:69454 6480464 [Buthionine Sulfoximine co-treated with Lovastatin co-treated with Gemfibrozil] results in increased expression of LCN2 mRNA CTD PMID:30853469 maleic acid multiple interactions EXP 6480464 Curcumin inhibits the reaction [maleic acid results in increased secretion of LCN2 protein] CTD PMID:25119790 maleic acid increases secretion EXP 6480464 maleic acid results in increased secretion of LCN2 protein CTD PMID:25119790 Mecamylamine multiple interactions ISO RGD:69454 6480464 [Cyclophosphamide co-treated with Mecamylamine] results in increased expression of LCN2 mRNA CTD PMID:18433785 medroxyprogesterone acetate multiple interactions ISO RGD:69453 6480464 [Estradiol co-treated with Medroxyprogesterone Acetate] results in decreased expression of LCN2 mRNA CTD PMID:15866426 melamine multiple interactions EXP 6480464 [cyanuric acid co-treated with melamine] results in increased expression of LCN2 mRNA, [melamine co-treated with cyanuric acid] results in increased expression of LCN2 mRNA CTD PMID:21784140 , PMID:23022069 melamine increases expression EXP 6480464 melamine results in increased expression of LCN2 CTD PMID:23052191 mercury atom increases expression EXP 6480464 Mercury results in increased expression of LCN2 mRNA CTD PMID:25145654 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of LCN2 mRNA CTD PMID:16507785 more ... mercury dichloride increases expression ISO RGD:69454 6480464 Mercuric Chloride results in increased expression of LCN2 mRNA CTD PMID:27720909 mercury dichloride decreases secretion ISO RGD:69453 6480464 Mercuric Chloride results in decreased secretion of LCN2 protein CTD PMID:27888128 mercury(0) increases expression EXP 6480464 Mercury results in increased expression of LCN2 mRNA CTD PMID:25145654 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [[Streptozocin co-treated with Fructose] results in increased expression of LCN2 protein] CTD PMID:30551545 methimazole increases expression EXP 6480464 Methimazole results in increased expression of LCN2 mRNA CTD PMID:22504374 methotrexate multiple interactions EXP 6480464 vanillin inhibits the reaction [Methotrexate results in increased expression of LCN2 protein] CTD PMID:29216766 methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of LCN2 protein CTD PMID:29216766 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of LCN2 gene CTD PMID:23303685 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of LCN2 mRNA CTD PMID:28536007 methylmercury chloride increases expression ISO RGD:69454 6480464 methylmercuric chloride results in increased expression of LCN2 mRNA CTD PMID:27720909 microcystin-LR multiple interactions ISO RGD:69454 6480464 [cyanoginosin LR co-treated with LCN2 protein] results in decreased expression of CLDN5 protein more ... CTD PMID:34416350 microcystin-LR increases expression ISO RGD:69454 6480464 cyanoginosin LR results in increased expression of LCN2 protein CTD PMID:34416350 morphine increases expression ISO RGD:69454 6480464 Morphine results in increased expression of LCN2 mRNA CTD PMID:20144693 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of LCN2 mRNA CTD PMID:21515302 N-methyl-N-nitrosourea increases expression EXP 6480464 Methylnitrosourea results in increased expression of LCN2 mRNA CTD PMID:17412507 N-nitrosodiethylamine increases expression ISO RGD:69454 6480464 Diethylnitrosamine results in increased expression of LCN2 mRNA CTD PMID:12771043 , PMID:24535843 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LCN2 mRNA CTD PMID:28943392 N-nitrosodiethylamine multiple interactions ISO RGD:69454 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LCN2 mRNA CTD PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of LCN2 mRNA CTD PMID:17072980 , PMID:25380136 natamycin increases expression ISO RGD:69454 6480464 Natamycin results in increased expression of LCN2 mRNA CTD PMID:22863853 nickel atom increases expression ISO RGD:69454 6480464 Nickel results in increased expression of LCN2 mRNA CTD PMID:12540486 nickel atom increases expression ISO RGD:69453 6480464 Nickel results in increased expression of LCN2 mRNA CTD PMID:24768652 , PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of LCN2 mRNA CTD PMID:22546817 nickel sulfate increases expression ISO RGD:69454 6480464 nickel sulfate results in increased expression of LCN2 mRNA CTD PMID:16100012 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of LCN2 mRNA, nitrofen results in increased expression of LCN2 protein CTD PMID:23114405 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of LCN2 mRNA CTD PMID:27592368 , PMID:33484710 nystatin increases expression ISO RGD:69454 6480464 Nystatin results in increased expression of LCN2 mRNA CTD PMID:22863853 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of LCN2, ochratoxin A results in increased expression of LCN2 mRNA CTD PMID:18308701 , PMID:25218026 ochratoxin A multiple interactions ISO RGD:69454 6480464 [1-aminobenzotriazole co-treated with ochratoxin A] results in increased expression of LCN2 protein CTD PMID:36227364 Ondansetron multiple interactions ISO RGD:69454 6480464 Ondansetron promotes the reaction [Cisplatin results in increased expression of LCN2 mRNA] CTD PMID:24001450 ozone multiple interactions ISO RGD:69454 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LCN2 mRNA more ... CTD PMID:19555225 more ... ozone increases expression ISO RGD:69453 6480464 Ozone results in increased expression of LCN2 mRNA CTD PMID:23033980 ozone increases expression ISO RGD:69454 6480464 Ozone results in increased expression of LCN2 mRNA, Ozone results in increased expression of LCN2 protein CTD PMID:12763052 more ... palmitoyl ethanolamide multiple interactions EXP 6480464 palmidrol analog inhibits the reaction [[Streptozocin co-treated with iomeprol] results in increased expression of LCN2 protein] CTD PMID:26474837 paracetamol multiple interactions ISO RGD:69454 6480464 IL22 protein promotes the reaction [Acetaminophen results in increased expression of LCN2 mRNA] more ... CTD PMID:22461450 more ... paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of LCN2 mRNA CTD PMID:33387578 paracetamol decreases secretion ISO RGD:69453 6480464 Acetaminophen results in decreased secretion of LCN2 protein CTD PMID:27888128 paracetamol decreases expression ISO RGD:69453 6480464 Acetaminophen results in decreased expression of LCN2 mRNA CTD PMID:27888128 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of LCN2 mRNA CTD PMID:20623750 paracetamol affects expression ISO RGD:69454 6480464 Acetaminophen affects the expression of LCN2 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:69454 6480464 Acetaminophen results in increased expression of LCN2 mRNA, Acetaminophen results in increased expression of LCN2 protein CTD PMID:20100502 more ... paraquat multiple interactions ISO RGD:69454 6480464 [ABCB1A gene mutant form results in increased susceptibility to Paraquat] which results in increased expression of LCN2 mRNA more ... CTD PMID:25015657 , PMID:33838153 paraquat increases secretion ISO RGD:69454 6480464 Paraquat results in increased secretion of LCN2 protein CTD PMID:33838153 paraquat increases expression ISO RGD:69454 6480464 Paraquat results in increased expression of LCN2 mRNA, Paraquat results in increased expression of LCN2 protein CTD PMID:21463325 , PMID:26345256 perfluorononanoic acid multiple interactions ISO RGD:69454 6480464 [Dietary Fats co-treated with perfluoro-n-nonanoic acid] results in decreased expression of LCN2 mRNA CTD PMID:33483757 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:69454 6480464 [Dietary Fats co-treated with perfluorooctane sulfonic acid] results in decreased expression of LCN2 mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of LCN2 mRNA CTD PMID:33483757 , PMID:36331819 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:69454 6480464 perfluorooctane sulfonic acid results in decreased expression of LCN2 mRNA CTD PMID:31926186 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of LCN2 mRNA CTD PMID:28973641 phenobarbital increases expression ISO RGD:69454 6480464 Phenobarbital results in increased expression of LCN2 mRNA CTD PMID:19270015 phenobarbital affects expression ISO RGD:69454 6480464 Phenobarbital affects the expression of LCN2 mRNA CTD PMID:23091169 phenobarbital multiple interactions ISO RGD:69454 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LCN2 mRNA CTD PMID:24535843 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of LCN2 mRNA CTD PMID:15215175 pirinixic acid decreases expression ISO RGD:69454 6480464 pirinixic acid results in decreased expression of LCN2 mRNA CTD PMID:17321000 pirinixic acid multiple interactions ISO RGD:69454 6480464 pirinixic acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of LCN2 mRNA] more ... CTD PMID:17321000 , PMID:27853831 pirinixic acid increases expression ISO RGD:69454 6480464 pirinixic acid results in increased expression of LCN2 mRNA CTD PMID:18445702 potassium bromate multiple interactions ISO RGD:69454 6480464 [XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LCN2 mRNA] CTD PMID:27082013 prednisolone decreases secretion ISO RGD:69454 6480464 Prednisolone results in decreased secretion of LCN2 protein CTD PMID:28003376 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:69454 6480464 Pregnenolone Carbonitrile results in increased expression of LCN2 mRNA CTD PMID:28903501 procymidone decreases expression ISO RGD:69454 6480464 procymidone results in decreased expression of LCN2 mRNA CTD PMID:36764477 progesterone affects expression ISO RGD:69454 6480464 Progesterone affects the expression of LCN2 mRNA CTD PMID:17251523 propanal increases expression ISO RGD:69453 6480464 propionaldehyde results in increased expression of LCN2 mRNA CTD PMID:26079696 propiconazole increases expression ISO RGD:69454 6480464 propiconazole results in increased expression of LCN2 mRNA CTD PMID:21278054 protein kinase inhibitor decreases secretion ISO RGD:69454 6480464 Protein Kinase Inhibitors results in decreased secretion of LCN2 protein CTD PMID:28003376 pyrrolidine dithiocarbamate multiple interactions ISO RGD:69454 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [lead acetate results in increased expression of LCN2 mRNA] CTD PMID:36539177 quartz increases expression EXP 6480464 Quartz results in increased expression of LCN2 mRNA CTD PMID:19836432 rac-lactic acid decreases expression ISO RGD:69453 6480464 Lactic Acid results in decreased expression of LCN2 mRNA CTD PMID:30851411 raloxifene affects expression ISO RGD:69453 6480464 Raloxifene Hydrochloride affects the expression of LCN2 mRNA CTD PMID:14699072 resveratrol decreases expression ISO RGD:69454 6480464 resveratrol results in decreased expression of LCN2 protein CTD PMID:25505154 resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of LCN2 protein CTD PMID:25895148 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of LCN2 mRNA CTD PMID:25905778 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of LCN2 mRNA CTD PMID:25905778 Rhynchophylline multiple interactions ISO RGD:69454 6480464 rhyncophylline inhibits the reaction [Paraquat results in increased secretion of LCN2 protein] CTD PMID:33838153 ritodrine increases expression ISO RGD:69454 6480464 Ritodrine results in increased expression of LCN2 mRNA CTD PMID:23370008 rotenone multiple interactions ISO RGD:69454 6480464 Rotenone inhibits the reaction [Acetaminophen results in increased expression of LCN2 mRNA], Rotenone inhibits the reaction [Acetaminophen results in increased expression of LCN2 protein] CTD PMID:30099449 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 Diclofenac promotes the reaction [Buthionine Sulfoximine results in increased expression of LCN2 mRNA] CTD PMID:23939143 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions ISO RGD:69454 6480464 [Buthionine Sulfoximine co-treated with Atorvastatin co-treated with Ciprofloxacin] results in increased expression of LCN2 mRNA more ... CTD PMID:29154782 more ... S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression EXP 6480464 Buthionine Sulfoximine results in increased expression of LCN2 mRNA CTD PMID:23939143 senecionine increases expression ISO RGD:69454 6480464 senecionine results in increased expression of LCN2 mRNA CTD PMID:31606820 serpentine asbestos increases expression ISO RGD:69454 6480464 Asbestos, Serpentine results in increased expression of LCN2 mRNA CTD PMID:16251409 sevoflurane increases secretion ISO RGD:69454 6480464 Sevoflurane results in increased secretion of LCN2 protein CTD PMID:30538007 silicon dioxide decreases expression ISO RGD:69453 6480464 Silicon Dioxide analog results in decreased expression of LCN2 mRNA, Silicon Dioxide results in decreased expression of LCN2 mRNA CTD PMID:25895662 , PMID:28425640 silicon dioxide increases expression ISO RGD:69454 6480464 Silicon Dioxide results in increased expression of LCN2 mRNA, Silicon Dioxide results in increased expression of LCN2 protein CTD PMID:23221170 more ... silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of LCN2 mRNA CTD PMID:22431001 sirolimus increases expression EXP 6480464 Sirolimus results in increased expression of LCN2 mRNA CTD PMID:21865292 sodium arsenate increases expression ISO RGD:69454 6480464 sodium arsenate results in increased expression of LCN2 mRNA CTD PMID:21795629 sodium arsenite increases secretion EXP 6480464 sodium arsenite results in increased secretion of LCN2 protein CTD PMID:32736004 sodium arsenite decreases expression ISO RGD:69453 6480464 sodium arsenite results in decreased expression of LCN2 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:69453 6480464 sodium arsenite results in increased expression of LCN2 mRNA, sodium arsenite results in increased expression of LCN2 protein CTD PMID:24570342 sodium arsenite decreases methylation ISO RGD:69453 6480464 sodium arsenite results in decreased methylation of LCN2 gene, sodium arsenite results in decreased methylation of LCN2 promoter CTD PMID:24570342 sodium arsenite multiple interactions ISO RGD:69453 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [sodium arsenite results in increased expression of LCN2 mRNA] more ... CTD PMID:24570342 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of LCN2 mRNA CTD PMID:25993096 sodium dodecyl sulfate increases expression ISO RGD:69453 6480464 Sodium Dodecyl Sulfate results in increased expression of LCN2 mRNA CTD PMID:31734321 Soman increases expression EXP 6480464 Soman results in increased expression of LCN2 mRNA CTD PMID:19281266 streptozocin multiple interactions EXP 6480464 [Resveratrol co-treated with Streptozocin] results in increased expression of LCN2 mRNA more ... CTD PMID:25905778 more ... streptozocin multiple interactions ISO RGD:69454 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of LCN2 mRNA, Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of LCN2 mRNA] CTD PMID:33484791 succimer multiple interactions ISO RGD:69454 6480464 [Magnetite Nanoparticles co-treated with Succimer] results in increased expression of LCN2 mRNA more ... CTD PMID:21641980 more ... tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of LCN2 mRNA CTD PMID:21865292 tacrolimus hydrate increases expression ISO RGD:69453 6480464 Tacrolimus results in increased expression of LCN2 mRNA CTD PMID:29362864 tacrolimus hydrate increases expression ISO RGD:69454 6480464 Tacrolimus results in increased expression of LCN2 mRNA CTD PMID:29362864 tamoxifen affects expression ISO RGD:69453 6480464 Tamoxifen affects the expression of LCN2 mRNA CTD PMID:14699072 tamoxifen affects expression ISO RGD:69454 6480464 Tamoxifen affects the expression of LCN2 mRNA CTD PMID:20937368 tannic acid multiple interactions EXP 6480464 Tannic Acid inhibits the reaction [Doxorubicin results in increased expression of LCN2 mRNA] CTD PMID:35987278 tert-butyl hydroperoxide decreases secretion ISO RGD:69453 6480464 tert-Butylhydroperoxide results in decreased secretion of LCN2 protein CTD PMID:27888128 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of LCN2 mRNA CTD PMID:32741896 tetrachloromethane multiple interactions ISO RGD:69454 6480464 [Ethanol co-treated with Carbon Tetrachloride] results in increased expression of LCN2 mRNA, PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of LCN2 mRNA] CTD PMID:16006527 , PMID:28285099 tetrachloromethane multiple interactions EXP 6480464 Anthocyanins inhibits the reaction [Carbon Tetrachloride results in increased expression of LCN2 protein], schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LCN2 mRNA] CTD PMID:30825423 , PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of LCN2 mRNA, Carbon Tetrachloride results in increased expression of LCN2 protein CTD PMID:30723492 more ... tetrachloromethane increases expression ISO RGD:69454 6480464 Carbon Tetrachloride results in increased expression of LCN2 mRNA CTD PMID:27339419 more ... tetrachloromethane affects expression ISO RGD:69454 6480464 Carbon Tetrachloride affects the expression of LCN2 mRNA CTD PMID:17484886 thapsigargin increases expression ISO RGD:69453 6480464 Thapsigargin results in increased expression of LCN2 mRNA CTD PMID:22800509 thapsigargin multiple interactions ISO RGD:69453 6480464 Thapsigargin promotes the reaction [DDIT3 protein binds to LCN2 promoter], Thapsigargin results in increased expression of and results in increased secretion of LCN2 protein CTD PMID:22800509 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LCN2 mRNA CTD PMID:28943392 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of LCN2 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:69454 6480464 titanium dioxide results in decreased expression of LCN2 mRNA CTD PMID:23131501 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of LCN2 mRNA CTD PMID:30012374 titanium dioxide affects expression ISO RGD:69454 6480464 titanium dioxide affects the expression of LCN2 mRNA CTD PMID:17656681 titanium dioxide increases expression ISO RGD:69454 6480464 titanium dioxide results in increased expression of LCN2 mRNA, titanium dioxide results in increased expression of LCN2 protein CTD PMID:21259345 more ... trichloroethene increases expression ISO RGD:69454 6480464 Trichloroethylene results in increased expression of LCN2 mRNA CTD PMID:25549359 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of LCN2 mRNA CTD PMID:33387578 trichloroethene decreases expression ISO RGD:69454 6480464 Trichloroethylene results in decreased expression of LCN2 mRNA CTD PMID:28973375 trimethyltin increases expression ISO RGD:69454 6480464 trimethyltin results in increased expression of LCN2 mRNA CTD PMID:24002884 triptonide increases expression ISO RGD:69454 6480464 triptonide results in increased expression of LCN2 mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of LCN2 mRNA CTD PMID:21515302 tungsten decreases expression ISO RGD:69454 6480464 Tungsten results in decreased expression of LCN2 mRNA CTD PMID:30912803 tunicamycin increases expression ISO RGD:69453 6480464 Tunicamycin results in increased expression of LCN2 mRNA CTD PMID:22800509 tunicamycin affects response to substance ISO RGD:69453 6480464 LCN2 mRNA affects the susceptibility to Tunicamycin CTD PMID:22800509 valproic acid increases expression ISO RGD:69453 6480464 Valproic Acid results in increased expression of LCN2 mRNA CTD PMID:29154799 , PMID:32623605 valproic acid increases methylation ISO RGD:69453 6480464 Valproic Acid results in increased methylation of LCN2 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:69453 6480464 CEBPA protein affects the reaction [Valproic Acid results in increased expression of LCN2 mRNA] CTD PMID:32623605 vancomycin increases expression EXP 6480464 Vancomycin results in increased expression of LCN2 mRNA CTD PMID:18289764 vanillin multiple interactions EXP 6480464 vanillin inhibits the reaction [Cisplatin results in increased expression of LCN2 protein], vanillin inhibits the reaction [Methotrexate results in increased expression of LCN2 protein] CTD PMID:29216766 vildagliptin multiple interactions EXP 6480464 Vildagliptin inhibits the reaction [Dietary Fats results in increased expression of LCN2 protein] CTD PMID:34081941 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of LCN2 mRNA CTD PMID:19015723 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of LCN2 mRNA CTD PMID:23034163 xylazine multiple interactions ISO RGD:69454 6480464 [Ketamine co-treated with Xylazine] results in decreased secretion of LCN2 protein CTD PMID:30538007 zoledronic acid increases expression ISO RGD:69453 6480464 zoledronic acid results in increased expression of LCN2 mRNA CTD PMID:24714768 zoledronic acid increases secretion ISO RGD:69453 6480464 zoledronic acid results in increased secretion of LCN2 protein CTD PMID:24714768 zomepirac multiple interactions ISO RGD:69454 6480464 [zomepirac co-treated with Buthionine Sulfoximine co-treated with tri-o-cresyl phosphate] results in increased expression of LCN2 mRNA, LY6G protein affects the reaction [[zomepirac co-treated with Buthionine Sulfoximine co-treated with tri-o-cresyl phosphate] results in increased expression of LCN2 mRNA] CTD PMID:29154782
